l-alpha-glycerophosphocholine

Small moleculeexperimental

Clinical trial activity

9 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
6

Earliest trial started Nov 1, 2010 (NCT01363648)

Timeline

2010s

  1. Jan 1, 2011

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO
Mol. weight
257.22 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • (2r)-2,3-dihydroxypropyl 2-(trimethylammonio)ethyl phosphate
  • (2r)-2,3-dihydroxypropyl 2-(trimethylammonio)ethyl phosphate
  • alpha-glycerophosphorylcholine
  • alpha-glycerophosphorylcholine
  • alpha-glycerophosphorylcholine
  • alpha-glycerylphosphorylcholine
  • choline alfoscerate
  • choline alfoscerate
  • choline alfoscerate
  • choline alfoscerate
  • choline alfoscerate
  • choline alfoscerate
  • choline alfoscerate
  • choline alphoscerate
  • choline alphoscerate
  • choline glycerophosphate
  • choline glycerophosphate
  • choline glycerophosphate
  • cholini glycerophosphas
  • cholini glycerophosphas
  • chonline alphoscerate
  • gliatilin
  • gliatilin
  • glicerofosfato de colina
  • glicerofosfato de colina
  • glycerol-3-phosphatidylcholine
  • glycerol-3-phosphatidylcholine
  • glycerol-3-phosphocholine
  • glycerol-3-phosphocholine
  • glycerol phosphorylcholine
  • glycerol phosphorylcholine
  • glycerol phosphorylcholine
  • glycerol phosphorylcholine
  • glycerophosphate de choline
  • glycerophosphate de choline
  • glycerophosphocholine
  • glycerophosphocholine
  • glycerophosphocholine
  • glycerophosphoric acid choline ester
  • glycerophosphorylcholine
  • glycerophosphorylcholine
  • glycerophosphorylcholine
  • glycerylphosphocholine
  • glycerylphosphorylcholine
  • glycerylphosphorylcholine
  • gpcho
  • gpcho
  • l-alpha-glycerophosphocholine
  • l-alpha-glycerophosphocholine
  • l-alpha-glycerophosphocholine
  • l-alpha-glycerophosphorylcholine
  • l-alpha-glycerophosphorylcholine
  • l-alpha glycerylphosphorylcholine
  • l-alpha glycerylphosphorylcholine
  • sn-3-gpc
  • sn-3-gpc
  • sn-glycero-3-phosphocholine
  • sn-glycero-3-phosphocholine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05383183Phase 4Jan 13, 2022Daewoong Pharmaceutical Co. LTD.
NCT05041790Phase 4Sep 30, 2021Choline Alfoscerate Re-evaluation Consortium, Chong Kun Dang Pharmaceutical, University of Ulsan
NCT05050604Phase 4Sep 30, 2021Choline Alfoscerate Re-evaluation Consortium, Chong Kun Dang Pharmaceutical, University of Ulsan
NCT03059069Phase 4Jun 1, 2016Yonsei University
NCT03249259Phase 3Mar 10, 2016Seoul National University
NCT02648906Phase 4Jul 1, 2015Daewoong Pharmaceutical Co. LTD.
NCT02395926Phase 1Oct 1, 2013Hyundai, Sungkyunkwan University
NCT01388738Phase 3Jan 1, 2011Clinical Institute of the Brain, Russia, Ever Neuro Pharma GmbH, Nycomed, Veropharm
NCT01363648Phase 4Nov 1, 2010Seoul National University
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Choline Alfoscerate Re-evaluation ConsortiumAcademic/Hospital2012021
Chong Kun Dang PharmaceuticalFor profit2212021
Daewoong Pharmaceutical Co. LTD.For profit2212015
Seoul National UniversityAcademic/Hospital2222010
University of UlsanAcademic/Hospital2012021
Clinical Institute of the Brain, RussiaAcademic/Hospital1112011
Ever Neuro Pharma GmbHFor profit1012011
HyundaiFor profit1112013
NycomedFor profit1012011
Sungkyunkwan UniversityAcademic/Hospital1012013
VeropharmFor profit1012011
Yonsei UniversityAcademic/Hospital1112016
12 organizations
Page 1 / 1